Notify me when Sofinnova Crossover I files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVA | Inventiva, S.A. | Ordinary Shares, nominal value EUR0.01 per share | 8.6% | $108,981,346 | +$64,487,273 | 19,086,050 | +145% | Sofinnova Partners SAS, a French corporation | 31 Dec 2025 |
| ABVX | Abivax S.A. | Ordinary Shares, par value EUR0.01 per share | 7.7% | $863,002,246 | -$269,710,200 | 6,399,478 | -24% | Sofinnova Crossover I SLP | 12 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|